Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: Outcome with eculizumab

Nephrology Dialysis Transplantation

Volumn 29, Issue 3, 2014, Pages 565-572

  Delmas, Yahsou ^a   Vendrely, Benoît ^a   Clouzeau, Benjamin ^a   Bachir, Hiba ^a   Bui, Hoang Nam ^a   Lacraz, Adeline ^a,b   Hélou, Sébastien ^a,b   Bordes, Cécile ^a,b,c   Reffet, Armel ^d   Llanas, Brigitte ^a   Skopinski, Sophie ^d   Rolland, Patrick ^e   Gruson, Didier ^a,b   Combe, Christian ^a,b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CNRS Bordeaux Segalen University   (France)

^d HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^e INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

Complement inhibition; Eculizumab; Escherichia coli; Haemolytic uraemic syndrome; Thrombotic microangiopathy

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIBIOTIC AGENT; AZITHROMYCIN; CREATININE; ECULIZUMAB; FOLIC ACID; HEMOGLOBIN; IRON; LACTATE DEHYDROGENASE; MENINGOCOCCUS VACCINE; PENICILLIN V; RENIN INHIBITOR; SPIRAMYCIN; MONOCLONAL ANTIBODY;

ACUTE KIDNEY FAILURE; ADULT; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIALYSIS; DIARRHEA; DISEASE SEVERITY; DRUG INDUCED HEADACHE; EPIDEMIC; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O104:H4; ESCHERICHIA COLI O104:H4 INFECTION; FEMALE; FOLLOW UP; FRANCE; FUNCTIONAL ASSESSMENT; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; IMMUNOADSORPTION; KIDNEY FUNCTION; LIVER DISEASE; MALE; MENINGOCOCCOSIS; MIDDLE AGED; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS DISEASE; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REFERENCE VALUE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; THROMBOCYTE COUNT; TREATMENT FAILURE; VOMITING; COMPLICATION; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; KIDNEY; MICROBIOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; CHILD, PRESCHOOL; DIARRHEA; DISEASE OUTBREAKS; ESCHERICHIA COLI INFECTIONS; FEMALE; FRANCE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY; MALE; MIDDLE AGED; SHIGA-TOXIGENIC ESCHERICHIA COLI; TREATMENT OUTCOME;

EID: 84895750286     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft470     Document Type: Article

References (44)

1. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600
2. Ruggenenti P, Remuzzi G. A German outbreak of haemolytic uraemic syndrome. Lancet 2011; 378: 1057-1058
3. Szczepiorkowski ZM, Winters JL, Bandarenko N et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177
4. Clark WF. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Semin Dial 2012; 25: 214-219
5. Bambauer R, Latza R, Schiel R. Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects. Ther Apher Dial 2011; 15: 10-19
6. Loirat C, Sonsino E, Hinglais N et al. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology. Pediatr Nephrol 1988; 2: 279-285
7. Michael M, Elliott EJ, Ridley GF et al. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 2009; 1: CD003595
8. Buchholz U, Bernard H, Werber D et al. German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med 2011; 365: 1763-1770
9. Askar M, Faber MS, Frank C et al. Update on the ongoing outbreak of haemolytic uraemic syndrome due to Shiga toxin-producing Escherichia coli (STEC) serotype O104, Germany, May 2011. Euro Surveill 2011; 16: pii=19883
10. Bielaszewska M, Mellmann A, Zhang W et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011; 11: 671-676
11. Frank C, Werber D, Cramer JP et al. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011; 365: 1771-1780
12. Kielstein JT, Beutel G, Fleig S et al. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry. Nephrol Dial Transplant 2012; 27: 3807-3815
13. Loos S, Ahlenstiel T, Kranz B et al. An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis 2012; 55: 753-759
14. Bae WK, Lee YK, Cho MS et al. A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4. Yonsei Med J 2006; 47: 437-439
15. Ruggenenti P, Remuzzi G. Thrombotic microangiopathy: E. coli O104:H4 German outbreak: a missed opportunity. Nat Rev Nephrol 2012; 8: 558-560
16. Colic E, Dieperink H, Titlestad K et al. Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study. Lancet 2011; 378: 1089-1093
17. Menne J, Nitschke M, Stingele R et al. Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 2012; 345: e4565
18. Greinacher A, Friesecke S, Abel P et al. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 2011; 378: 1166-1173
19. Kunzendorf U, Karch H, Werber D et al. Recent outbreak of hemolytic uremic syndrome in Germany. Kidney Int 2011; 80: 900-902
20. Dolgin E. As E. coli continues to claim lives, new approaches offer hope. Nat Med 2011; 17: 755
21. Legendre CM, Licht C, Muus P et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 2013; 368: 2169-2181
22. AFSSAPS. Agence française de sécurité sanitaire des produits de santé. Point d'information de l'Afssaps sur l'utilisation de Soliris dans le SHU post diarrhéique à shiga toxine produite par E. coli. June 3, 2011. Available from: http://www.afssaps.fr/Infos-de-securite/ Points-d-information/Utilisation-de-Soliris-dans-le-SHU-post-diarrheique-a- shiga-toxineproduite- par-E.coli-Point-d-information. (3 June 2011, date last accessed)
23. Lapeyraque A-L, Malina M, Frémeaux-Bacchi V et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 2011; 364: 2561-2563
24. Aldabe B, Delmas Y, Gault G et al. Household transmission of haemolytic uraemic syndrome associated with Escherichia coli O104:H4, southwestern France, June 2011. Euro Surveill 2011; 16: pii=19934
25. King LA, Nogareda F, Weill F-X et al. Outbreak of Shiga toxin-producing Escherichia coli O104:H4 associated with organic fenugreek sprouts, France, June 2011. Clin Infect Dis 2012; 54: 1588-1594
26. Mariani-Kurkdjian P, Bingen E, Gault G et al. Escherichia coli O104:H4 south-west France, June 2011. Lancet Infect Dis 2011; 11: 732-733
27. Grad YH, Lipsitch M, Feldgarden M et al. Genomic epidemiology of the Escherichia coli O104:H4 outbreaks in Europe, 2011. Proc Natl Acad Sci USA 2012; 109: 3065-3070
28. Gault G, Weill F, Mariani-Kurkdjian P et al. Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli O104:H4, south-west France, June 2011. Euro Surveill 2011; 16: pii=19905
29. Wong CS, Jelacic S, Habeeb RL et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections. N Engl J Med 2000; 342: 1930-1936
30. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
31. Combe C, Bui HN, de Precigout V et al. Immunoadsorption in patients with haemolytic uraemic syndrome. Lancet 2012; 379: 517-518; author reply 8-9
32. Robert Koch Institute. Report: final presentation and evaluation of epidemiological findings in the EHEC O104:H4 outbreak, Germany 2011. 2012. http://www.rki.de/EN/Home/EHEC-final-report.html
33. Artunc F. Treating Shiga toxin induced haemolytic uraemic syndrome. BMJ 2012; 345: e4598
34. Nitschke M, Sayk F, Härtel C et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 2012; 307: 1046-1052
35. EMA: European Medicines Agency. Soliris: EPAR - Product Information. 2012. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR- -Product-Information/human/000791/WC500054208.pdf (27 July 2012, date last accessed)
36. Morigi M, Galbusera M, Gastoldi S et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 2011; 187: 172-180
37. Orth D, Würzner R. Complement in typical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 620-624
38. Ståhl A-L, Sartz L, Karpman D. Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coliinduced hemolytic uremic syndrome. Blood 2011; 117: 5503-5513
39. Orth D, Khan AB, Naim A et al. Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome. J Immunol 2009; 182: 6394-6400
40. Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012; 8: 622-633
41. Thurman JM, Marians R, Emlen W et al. Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2009; 4: 1920-1924
42. Shelat SG. Practical considerations for planning a therapeutic apheresis procedure. Am J Med 2010; 123: 777-784
43. Karpman D. Management of Shiga toxin-associated Escherichia coliinduced haemolytic uraemic syndrome: randomized clinical trials are needed. Nephrol Dial Transplant 2012; 27: 3669-3674
44. Harendza S. 'HUS diary' of a German nephrologist during the current EHEC outbreak in Europe. Kidney Int 2011; 80: 687-689